The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Abstract
In obesity and type 2 diabetes, expression of the GLUT4 glucose transporter is decreased selectively in adipocytes. Adipose-specific Glut4 (also known as Slc2a4) knockout (adipose-Glut4(-/-)) mice show insulin resistance secondarily in muscle and liver. Here we show, using DNA arrays, that expression of retinol binding protein-4 (RBP4) is elevated in adipose tissue of adipose-Glut4(-/-) mice. We show that serum RBP4 levels are elevated in insulin-resistant mice and humans with obesity and type 2 diabetes. RBP4 levels are normalized by rosiglitazone, an insulin-sensitizing drug. Transgenic overexpression of human RBP4 or injection of recombinant RBP4 in normal mice causes insulin resistance. Conversely, genetic deletion of Rbp4 enhances insulin sensitivity. Fenretinide, a synthetic retinoid that increases urinary excretion of RBP4, normalizes serum RBP4 levels and improves insulin resistance and glucose intolerance in mice with obesity induced by a high-fat diet. Increasing serum RBP4 induces hepatic expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and impairs insulin signalling in muscle. Thus, RBP4 is an adipocyte-derived 'signal' that may contribute to the pathogenesis of type 2 diabetes. Lowering RBP4 could be a new strategy for treating type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The secretion of these proinflammatory cytokines and chemokines, as well as the secretion of other adipokines like retinol binding protein 4 (RBP4) 141, 142, is now well admitted to contribute to the onset of the physiological alterations accompanying obesity 12.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [141]
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637
Self-citationGlucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295
Self-citationAdipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O. D., Kim, J. K., Kim, Y., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,276
Self-citationMinireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
Lee, C., Olson, P., & Evans, R. M. (2003) · Endocrinology · doi:10.1210/en.2003-0288 · Cited by 891
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832
Nutrient Requirements of Laboratory Animals,
National Research Council (1995) · National Academies Press eBooks · doi:10.17226/4758 · Cited by 735
Flagged first, then by citations
Research works printed but not linked: 1
- Kotani, K., Kim, Y. B., Peroni, O., Mundt, A. & Kahn, B. B. Rosiglitazone treatment normalizes glucose tolerance in adipose-specific GLUT4 knockout mice but renders muscle-specific GLUT4 knockout more diabetic [abstract]. Diabetes 50, A274 (2001)
Cited by
Sorted by citations
Items 701–800 of 1,003
Petrák, J. (2011) · Oncology Reports · doi:10.3892/or.2011.1513 · Cited by 45
Jeyakumar, S. M., & Vajreswari, A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.156554 · Cited by 45
Karre, S. (2015) · Medical Science Monitor · doi:10.12659/msm.891043 · Cited by 45
Tanrıkulu-Kılıç, F., Bekpınar, S., Ünlüçerçi, Y., & Orhan, Y. (2006) · Physiological Research · doi:10.33549/physiolres.930745 · Cited by 45
Liao, Y., Takashima, S., ZHAO, H., ASANO, Y., Shintani, Y., Minamino, T., KIM, J., Fujita, M., HORI, M., & Kitakaze, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.021 · Cited by 45
Influence of Age on the Association of Retinol‐binding Protein 4 With Metabolic Syndrome
Gavi, S., Qurashi, S., Stuart, L. M., Lau, R. G., Meléndez, M. M., Mynarcik, D. C., McNurlan, M. A., & Gelato, M. C. (2008) · Obesity · doi:10.1038/oby.2007.138 · Cited by 45
Wysocki, M., Chen, H., Steibel, J. P., Kuhar, D., Petry, D. B., Bates, J., Johnson, R. K., Ernst, C. W., & Lunney, J. K. (2011) · Animal Genetics · doi:10.1111/j.1365-2052.2011.02251.x · Cited by 44
Dai, Z., Qi, W., Li, C., Lu, J., Mao, Y., Yao, Y., Li, L., Zhang, T., Hong, H., Li, S., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.001 · Cited by 44
Chávez, A. O., Coletta, D. K., Kamath, S., Cromack, D. T., Monroy, A., Folli, F. B., DeFronzo, R. A., & Tripathy, D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90737.2008 · Cited by 45
Zachariah, J. P. V., Quiroz, R., Nelson, K. P., Teng, Z., Keaney, J. F., SULLIVAN, L. M., & Vasan, R. S. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004974 · Cited by 44
Scotece, M., Koskinen-Kolasa, A., Pemmari, A., Leppänen, T., Hämäläinen, M., Moilanen, T. P. S., Moilanen, E., & Vuolteenaho, K. (2020) · Inflammation Research · doi:10.1007/s00011-020-01326-0 · Cited by 45
Mahdavi, A., Bagherniya, M., Mirenayat, M. S., Atkin, S. L., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-64872-5_13 · Cited by 44
Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer
Zhao, J., & Lawless, M. W. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.009 · Cited by 45
MUÑOZ, S. A., Franckhauser, S., Elias, I., Ferré, T., Hidalgo, A., Monteys, A. M., Molas, M., Cerdán, S., Pujol, A., Ruberte, J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1840-7 · Cited by 44
Novel role for retinol-binding protein 4 in the regulation of blood pressure
Kraus, B. J., Sartoretto, J. L., Polak, P., Hosooka, T., Shiroto, T., Eskurza, I., Lee, S., Jiang, H., Michel, T. M., & Kahn, B. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-266064 · Cited by 44
Self-citationFernández‐Real, J. M., Moreno‐Navarrete, J. M., & Ricart, W. (2008) · Diabetes · doi:10.2337/db08-0041 · Cited by 44
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Liu, Y., Mu, D., Chen, H., Li, D., Song, J., Yuan, Ž., & Xia, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1320 · Cited by 44
Pharmacological effects of lipid-lowering drugs on circulating adipokines
Wanders, D. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i4.116 · Cited by 43
Lauritzen, H. P. M. M., Ploug, T., Ai, H., Donsmark, M., Prats, C., & Galbo, H. (2007) · Diabetes · doi:10.2337/db07-0516 · Cited by 45
Vitamin A, endocrine tissues and hormones: interplay and interactions
Brossaud, J., Pallet, V., & Corcuff, J. (2017) · Endocrine Connections · doi:10.1530/ec-17-0101 · Cited by 49
Eldor, R., & Raz, I. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.004 · Cited by 43
Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus
Ismail, T. A., Soliman, M. M., & NASSAN, M. A. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2354 · Cited by 43
Cho, K. W., Zhou, Y., Sheng, L., & Rui, L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00459-10 · Cited by 42
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 45
Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis
Park, J., Cha, D. H., Lee, S. J., Kim, Y. N., Kim, Y. H., & Kim, K. P. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.7.047 · Cited by 42
Wu, Y., Li, H., Loos, R. J. F., Qi, Q., Hu, F. B., Liu, Y., & Lin, X. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900014-jlr200 · Cited by 42
Jufvas, Å., Sjödin, S., Lundqvist, K., Amin, R., Vener, A. V., & Strålfors, P. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-15 · Cited by 43
Circulating Adipokines and Vascular Function
Zachariah, J. P. V., Hwang, S., Hamburg, N. M., Benjamin, E. J., Larson, M. G., Levy, D. A., Vita, J. A., SULLIVAN, L. M., Mitchell, G. F., & Vasan, R. S. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05949 · Cited by 42
Kahn, B. B. (2018) · Diabetes · doi:10.2337/dbi18-0035 · Cited by 45
Self-citationLewandowski, K. C., Stojanovic, N. D., Bieńkiewicz, M., Tan, B. K., Prelević, G. M., Press, M., Tuck, S. M., O'Hare, P. J., & Randeva, H. S. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802141052 · Cited by 42
Bexarotene as Add-On to Antipsychotic Treatment in Schizophrenia Patients
Lerner, V., Miodownik, C., Gibel, A., Kovalyonok, E., Shleifer, T., Goodman, A. B., & Ritsner, M. S. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31806450da · Cited by 42
Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS
Yıldız, B. O., Bozdağ, G., Otegen, U., Harmancı, A., Boynukalin, K., Vural, Z., Kirazlı, Ş., & Yaralı́, H. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.10.016 · Cited by 42
Zanotti, G., Folli, C., Cendron, L., Alfieri, B., Nishida, S. K., Gliubich, F., Pasquato, N., Negro, A., & Berni, R. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06705.x · Cited by 42
Hypothalamic Kisspeptin Neurons: Integral Elements of the GnRH System
Prashar, V., Arora, T., Singh, R., Sharma, A., & Parkash, J. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01027-5 · Cited by 46
Liu, Y., Wang, D., Chen, H., & Xia, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.11.016 · Cited by 41
Pullakhandam, R., Palika, R., Ghosh, S., & Reddy, G. B. (2012) · IUBMB Life · doi:10.1002/iub.1096 · Cited by 42
Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes
Akbay, E., Muşlu, N., Nayır, E., Ozhan, O., & KIYKIM, A. A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346678 · Cited by 41
Kwon, H., Huang, B., Jeoung, N. H., Wu, P., Steussy, C. N., & Harris, R. A. (2006) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2006.04.005 · Cited by 41
Schina, M., Koskinas, J. S., TINIAKOS, D. G., Hadziyannis, E. S., Savvas, S., Karamanos, B. G., Manesis, E. K., & Archimandritis, A. J. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00534.x · Cited by 41
Katterle, Y., Keipert, S., Hof, J., & Klaus, S. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00194.2007 · Cited by 41
A discovery-phase urine proteomics investigation in type 1 diabetes
Soggiù, A., Piras, C., Bonizzi, L., Hussein, H. A., Pisanu, S., & Roncada, P. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0407-0 · Cited by 41
HANSEN, E., Hajri, T., & Abumrad, N. N. (2006) · Surgery · doi:10.1016/j.surg.2005.10.018 · Cited by 41
Divergent synthesis and identification of the cellular targets of deoxyelephantopins
Lagoutte, R., Serba, C., Abegg, D., Hoch, D. G., Adibekian, A., & Winssinger, N. (2016) · Nature Communications · doi:10.1038/ncomms12470 · Cited by 41
Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis
Lim, J. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8325 · Cited by 40
Hayashi, Y., Suemitsu, E., Kajimoto, K., Sato, Y., Akhter, A., Sakurai, Y., Hatakeyama, H., Hyodo, M., Kaji, N., Baba, Y., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.4 · Cited by 40
Álvarez-Castro, P., Sangiao‐Alvarellos, S., Brandón-Sandá, I., & Cordido, F. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.008 · Cited by 41
Vitamin A Transport and Cell Signaling by the Retinol-Binding Protein Receptor STRA6
Noy, N. (2016) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-024-0945-1_3 · Cited by 41
Satish, M., Saxena, S. K., & Agrawal, D. K. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09879-0 · Cited by 40
Factors affecting obesity and its treatment
Singh, P., & Nand, S. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100140 · Cited by 41
Update on the genetic and epigenetic etiology of gestational diabetes mellitus: a review
Yahaya, T., Salisu, T. F., Abdulrahman, Y., & Umar, A. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00054-8 · Cited by 42
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 40
Imajo, K., Fujita, K., Yoneda, M., Shinohara, Y., Suzuki, K., Mawatari, H., Takahashi, J., Nozaki, Y., Sumida, Y., Kirikoshi, H., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.00976.x · Cited by 40
Redox regulation in anabolic and catabolic processes
Dröge, W. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000222098.98514.40 · Cited by 41
Heritability, Linkage, and Genetic Associations of Exercise Treadmill Test Responses
Ingelsson, E., Larson, M. G., Vasan, R. S., O’Donnell, C. J., Yin, X., Hirschhorn, J. N., Newton‐Cheh, C., Drake, J. A., Musone, S. L., Heard‐Costa, N. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.683821 · Cited by 40
Keicho, N., Matsushita, I., Tanaka, T., Shimbo, T., Hang, N. T. L., Sakurada, S., Kobayashi, N., Hijikata, M., Thuong, P. H., & Lien, L. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038703 · Cited by 40
Domingos, M. A. M., Moreira, S. R., Gómez, L. M. G., Goulart, A. C., Lotufo, P. A., Benseñor, I. M., & Titan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162782 · Cited by 39
Chen, X., Shen, T., Li, Q., Chen, X., Li, Y., Li, D., Chen, G., Ling, W., & Chen, Y. (2017) · Scientific Reports · doi:10.1038/srep45100 · Cited by 39
Carta, G., Melis, M., Pintus, S., Pintus, P., Piras, C. A., Muredda, L., Demurtas, D., Marzo, V. D., Banni, S., & Barbarossa, I. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-01562-1 · Cited by 39
Heliövaara, M. K., Remitz, A., Reitamo, S., Teppo, A., Karonen, S.-L., & Ebeling, P. (2007) · Metabolism · doi:10.1016/j.metabol.2007.02.002 · Cited by 39
Structure, Functions, and Implications of Selected Lipocalins in Human Disease
Chandrasekaran, P., Weiskirchen, S., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084290 · Cited by 39
Shirai, T., Shichi, Y., Sato, M., Tanioka, Y., Furusho, T., Ota, T., Tadokoro, T., Suzuki, T., Kobayashi, K., & Yamamoto, Y. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.11.018 · Cited by 38
Mcilroy, G. D., Tammireddy, S. R., Maskrey, B. H., Grant, L., Doherty, M. K., Watson, D. G., Delibegović, M., Whitfield, P. D., & Mody, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.017 · Cited by 38
Self-citationEndocrine-Disrupting Chemicals and Insulin Resistance in Children
Rotondo, E., & Chiarelli, F. (2020) · Biomedicines · doi:10.3390/biomedicines8060137 · Cited by 43
Kim, N., & Priefer, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113856 · Cited by 40
LRG1 is an adipokine that promotes insulin sensitivity and suppresses inflammation
Choi, C. H. J., Barr, W., Zaman, S., Model, C., Park, A., Koenen, M., Lin, Z., Szwed, S. K., Marchildon, F., Crane, A., et al. (2022) · eLife · doi:10.7554/elife.81559 · Cited by 39
Thévenod, F. (2008) · Frontiers in diabetes · doi:10.1159/000152019 · Cited by 38
Shin, E., Shin, S., Kong, H., Lee, S., Do, S., Jo, T. H., Park, Y.-I., Lee, C., Hwang, I. K., & Kim, K. (2011) · Immune Network · doi:10.4110/in.2011.11.2.107 · Cited by 38
Choi, S. H., Lee, Y. J., Park, Y. J., Kim, K. W., Lee, E. J., Lim, S. K., Park, D. J., Kim, S. E., Park, K. S., Jang, H. C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2536 · Cited by 38
Jiao, C., Cui, L., Ma, A., Li, N., & Si, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167498 · Cited by 38
Fu, J., Li, Y., Esangbedo, I. C., Li, G., Feng, D., Li, L., Xu, L., Han, L., Li, M., Li, C., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009169 · Cited by 37
Prashanth, G., Vastrad, B. M., Tengli, A., Vastrad, C. M., & Kotturshetti, I. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00718-5 · Cited by 39
Maghbooli, Z., Hossein‐Nezhad, A., Mirzaei, K., Karimi, F., Besharati, A., Omidfar, K., & Larijani, B. A. (2009) · Reproductive Sciences · doi:10.1177/1933719109351097 · Cited by 39
Sasaki, M., Otani, T., Kawakami, M., & Ishikawa, S. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.015 · Cited by 37
Petrukhin, K. E. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.05.004 · Cited by 39
Huang, S., & Yang, Y. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182722aee · Cited by 37
Huang, T., Tobias, D. K., Hruby, A., Rifai, N., Tworoger, S. S., & Hu, F. B. (2016) · Journal of Nutrition · doi:10.3945/jn.115.229666 · Cited by 43
Pleiotropic effects of niacin: Current possibilities for its clinical use
Zeman, M., Vecka, M., Perlík, F., Staňková, B., Hromádka, R., TVRZICKÁ, E., Širc, J., Hrib, J., & Žák, A. (2016) · Acta Pharmaceutica · doi:10.1515/acph-2016-0043 · Cited by 37
Rosenbohm, A., Nagel, G., Peter, R. S., Brehme, T., Köenig, W., Dupuis, L., Rothenbacher, D., Ludolph, A. C., & for the ALS Registry Study Group (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.5129 · Cited by 38
TET2 facilitates PPARγ agonist–mediated gene regulation and insulin sensitization in adipocytes
Bian, F., Ma, X., Villivalam, S. D., You, D., Choy, L. R., Paladugu, A., Fung, S., & Kang, S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.08.006 · Cited by 38
Vendrame, S., Zhao, A. S., Merrow, T., & Klimis‐Zacas, D. J. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.0065 · Cited by 37
Mitterberger, M. C., Mattesich, M., Klaver, E., Lechner, S., Engelhardt, T. O., Larcher, L., Pierer, G., Piza‐Katzer, H., & Zwerschke, W. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq107 · Cited by 37
Treating insulin resistance: future prospects
Bailey, C. J. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.002 · Cited by 37
Nanda, S., Nikoletakis, G., Markova, D. M., Poon, L. C., & Nicolaides, K. H. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.011 · Cited by 37
Increased Lipid Accumulation in Liver and White Adipose Tissue in Aging in the SAMP10 Mouse
Honma, T., Yanaka, M., Tsuduki, T., & Ikeda, I. (2011) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.57.123 · Cited by 37
Shangguan, X.-J., Liu, F., Wang, H., He, J., & Dong, M. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.06.031 · Cited by 37
Lee, S. J., Park, J.-W., Kim, I. A., Youn, B., & Gu, M. B. (2012) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2012.04.016 · Cited by 37
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Picomolar detection of retinol binding protein 4 for early management of type II diabetes
Paul, A., Chiriacò, M. S., Primiceri, E., Srivastava, D. N., & Maruccio, G. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.12.032 · Cited by 37
Yoshida, A., Matsutani, Y., Fukuchi, Y., Saito, K., & Naito, M. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.209 · Cited by 37
Retinol binding protein 4 and type 2 diabetes: from insulin resistance to pancreatic β-cell function
Fan, J., & Hu, J. (2024) · Endocrine · doi:10.1007/s12020-024-03777-5 · Cited by 38
Sepsis-Induced Adipokine Change with regard to Insulin Resistance
Hillenbrand, A., Weiß, M., Knippschild, U., Wolf, A. M., & Huber-Lang, M. S. (2012) · International Journal of Inflammation · doi:10.1155/2012/972368 · Cited by 39
Higuchi, K., Saito, I., Maruyama, K., Eguchi, E., Mori, H., Tanno, S., Sakurai, S., Kishida, T., Nishida, W., Osawa, H., et al. (2015) · Nutrition · doi:10.1016/j.nut.2015.02.015 · Cited by 36
The retinol-binding protein receptor STRA6 regulates diurnal insulin responses
Gliniak, C. M., Brown, J. M., & Noy, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782334 · Cited by 38
The mitochondrial PKCδ/retinol signal complex exerts real-time control on energy homeostasis
Kim, Y., & Hämmerling, U. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158614 · Cited by 36
Huang, R., Bai, X., Li, X., Wang, X., & Zhao, L. (2020) · Diabetes · doi:10.2337/db19-1241 · Cited by 36
Genetic variants for personalised management of very low carbohydrate ketogenic diets
Aronica, L., Volek, J. S., Poff, A. M., & D’Agostino, D. P. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000167 · Cited by 37
Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation
Guri, A. J., & Bassaganya-Riera, J. (2010) · Obesity · doi:10.1038/oby.2010.230 · Cited by 37
Sell, H., & Eckel, J. (2007) · Diabetologia · doi:10.1007/s00125-007-0764-3 · Cited by 36
Shin, E., Shim, K.-S., Kong, H., Lee, S., Shin, S., Kwon, J., Jo, T. H., Park, Y.-I., Lee, C., & Kim, K. (2011) · Immune Network · doi:10.4110/in.2011.11.1.59 · Cited by 37
Du, M., Otalora, L., Martin, A., Moiseyev, G. P., Vanlandingham, P. A., Wang, Q., Farjo, R. A., Yeganeh, A., Quiambao, A. B., & Farjo, K. M. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00181-15 · Cited by 36
Metadata
- Authors
- Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Columbia University (US)
- Corresponding author
- Kahn, Barbara B.
- Venue
- Nature
- Published
- 2005-07
- Volume
- 436
- Issue
- 7049
- Pages
- 356-362
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2092136583
- Cited by
- 2,086
- References
- 50
- Citations by year
- 2026: 43 · 2025: 50 · 2024: 80 · 2023: 53 · 2022: 85 · 2021: 86 · 2020: 95 · 2019: 69 · 2018: 76 · 2017: 91 · 2016: 88 · 2015: 120 · 2014: 115 · 2013: 124 · 2012: 135
- FWCI
- 89.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043051)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinol-binding protein 4, insulin resistance, type 2 diabetes, obesity, GLUT4, adipose tissue, rosiglitazone, fenretinide, phosphoenolpyruvate carboxykinase, hepatic gluconeogenesis, impaired glucose tolerance
- MeSH terms
- Rosiglitazone, Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Insulin, Insulin Resistance, Liver, Monosaccharide Transport Proteins, Muscle Proteins, Muscles, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Retinol-Binding Proteins, Signal Transduction, Mice, Knockout, Oligonucleotide Array Sequence Analysis, Hepatocytes, Thiazolidinediones, Glucose Transporter Type 4, Mice, Retinol-Binding Proteins, Plasma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review